PAR 3.41% 22.8¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-31

  1. 9,814 Posts.
    lightbulb Created with Sketch. 1249
    The realisation of ongoing P3 costs may be why we're indirectly hearing about "forward sale royalties"

    Not convinced its all over just yet in terms of funding options available rather there is elevated risks we don't get it on terms we had previous hoped.


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
22.8¢
Change
0.008(3.41%)
Mkt cap ! $80.45M
Open High Low Value Volume
22.5¢ 23.5¢ 22.5¢ $18.02K 79.03K

Buyers (Bids)

No. Vol. Price($)
6 151429 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
23.0¢ 130080 2
View Market Depth
Last trade - 13.26pm 15/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.